Primary hepatocytes isolated from the liver are effective tools for the in vitro evaluation of metabolism, drug-drug interactions, hepatotoxicity, and transporter activity. 

Gibco hepatocytes offer high viabilities routinely great than 80%, in vivo-like enzyme expression levels, and are characterized for phase I and phase II drug metabolizing enzyme activities. An extensive selection of lots and multiple large lots are available – ideal for reproducible long-term and multi-site studies.

Request more information

NEW Gibco Human Spheroid-Qualified Hepatocytes

Our Spheroid qualified hepatocytes are the first off-the-shelf cryopreserved human cells for generation of hepatic spheroids in your own lab. Each vial contains a minimum of five million viable cells, sufficient for up to sixteen 96-well plates of hepatic spheroids.

  • Maintain cells in culture longer—up to 21 days, >4X longer than cells last in monolayer culture
  • Design your own schedule—cells are ready for plating when you are
  • Interrogate pathways of interest—applicable for toxicity, metabolism, or disease modeling

Learn how you can research in the third dimension today

View our inventory to select lots that meet your specific needs

Gibco Hepatocyes and related products


Drug Discovery & Development Support Center

Find tips, troubleshooting help, and resources for support related to your drug discovery experiments.